Gene Expression Meta-Analysis Identifies VDAC1 as a Predictor of Poor Outcome in Early Stage Non-Small Cell Lung Cancer
2011
VDAC1 Predicts NSCLC Survival
Sample size: 602
publication
Evidence: high
Author Information
Author(s): Claire Grills, Jithesh Puthen V., Jaine Blayney, Shu-Dong Zhang, Dean A. Fennell
Primary Institution: Queen's University Belfast
Hypothesis
VDAC1 expression could impact survival following NSCLC resection.
Conclusion
High VDAC1 expression is associated with shorter overall survival in non-small cell lung cancer.
Supporting Evidence
- High VDAC1 expression was associated with shorter overall survival.
- VDAC1 was shown to be an independent prognostic factor.
- VDAC1 predicted shorter time to recurrence following NSCLC resection.
- Analysis included 8 independent NSCLC datasets.
Takeaway
This study found that a protein called VDAC1 can help predict how long patients with lung cancer will live after surgery.
Methodology
In vivo gene-expression meta-analysis of surgically resected NSCLC using 602 individual expression profiles.
Limitations
The study had a low number of samples for stages II and III, making it difficult to obtain statistically significant results.
Statistical Information
P-Value
0.0353
Confidence Interval
0.4528 to 0.9721
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website